10,536
Views
0
CrossRef citations to date
0
Altmetric
Research Article

An immune-related gene prognostic index for acute myeloid leukemia associated with regulatory T cells infiltration

, , , , , , , , , & show all

References

  • Fitzmaurice C, Abate D, Abbasi N, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5(12):1749–1768.
  • Döhner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015;373(12):1136–1152.
  • Yan Y, Zhang L, Zuo Y, et al. Immune checkpoint blockade in cancer immunotherapy: mechanisms, clinical outcomes, and safety profiles of PD-1/PD-L1 inhibitors. Arch Immunol Ther Exp. 2020;68(6):1–15.
  • Williams P, Basu S, Garcia-Manero G, et al. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia. Cancer. 2019;125(9):1470–1481.
  • Shenghui Z, Yixiang H, Jianbo W, et al. Elevated frequencies of CD4+ CD25+ CD127lo regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia. Int J Cancer. 2011;129(6):1373–1381.
  • Stirewalt DL, Meshinchi S, Kopecky KJ, et al. Identification of genes with abnormal expression changes in acute myeloid leukemia. Genes Chromosom Cancer. 2008;47(1):8–20.
  • Metzeler KH, Hummel M, Bloomfield CD, et al. An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia. Blood, J Am Soc Hematol. 2008;112(10):4193–4201.
  • Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;9(1):1–13.
  • Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1.
  • Jiang P, Gu S, Pan D, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24(10):1550–1558.
  • Sander FE, Nilsson M, Rydström A, et al. Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy. Cancer Immunol Immunother. 2017;66(11):1473–1484.
  • Zhao J, Wang L, Kong D, et al. Construction of novel DNA methylation-based prognostic model to predict survival in glioblastoma. J Comput Biol. 2020;27(5):718–728.
  • Yin H, Li Z, Chen J, et al. Expression and the potential functions of TRIM32 in lung cancer tumorigenesis. J Cell Biochem. 2019;120(4):5232–5243.
  • Wang C, Xu J, Fu H, et al. TRIM 32 promotes cell proliferation and invasion by activating β-catenin signalling in gastric cancer. J Cell Mol Med. 2018;22(10):5020–5028.
  • Yang SH, Liu W, Peng J, et al. High expression of RhoBTB3 predicts favorable chemotherapy outcomes in non-M3 acute myeloid leukemia. J Cancer. 2021;12(14):4229.
  • Brandl K, Tomisato W, Li X, et al. Yip1 domain family, member 6 (Yipf6) mutation induces spontaneous intestinal inflammation in mice. Proc Natl Acad Sci USA. 2012;109(31):12650–12655.
  • Bowman RL, Busque L, Levine RL. Clonal hematopoiesis and evolution to hematopoietic malignancies. Cell Stem Cell. 2018;22(2):157–170.
  • Bullinger L, Döhner K, Döhner H. Genomics of acute myeloid leukemia diagnosis and pathways. J Clin Oncol. 2017;35(9):934–946.
  • Corthay A. How do regulatory T cells work?. Scand J Immunol. 2009;70(4):326–336.
  • Du W, He J, Zhou W, et al. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia. J Transl Med. 2019;17(1):1–14.
  • Shen R, Postow MA, Adamow M, et al. LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade. Sci Transl Med. 2021;13(608):eabf5107.
  • Knaus HA, Berglund S, Hackl H, et al. Signatures of CD8+ T cell dysfunction in AML patients and their reversibility with response to chemotherapy. JCI Insight. 2018;3(21).
  • Tabata R, Chi SG, Yuda J, et al. Emerging immunotherapy for acute myeloid leukemia. Int J Mol Sci. 2021;22(4):1944.
  • Li L, Cui Y, Shen J, et al. Evidence for activated Lck protein tyrosine kinase as the driver of proliferation in acute myeloid leukemia cell, CTV-1. Leuk Res. 2019;78:12–20.